Amyloid Clinical Trial
Official title:
Detection of Amyloid Deposits in the Wrist by MRI With Mapping and High Resolution Sequences in Systemic Amyloidosis
This study is based on the hypothesis that MRI could make it possible to non-invasively detect these amyloid deposits at the level of the wrist using parametric sequences known as T1 mapping, in the form of an extension of T1 in the wrists. areas where amyloid deposits are found in the wrist.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05200897 -
Transdermal Trigeminal Electrical Neuromodulation on Mild Cognitive Impairment With Insomnia
|
N/A | |
Completed |
NCT03923920 -
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
|
||
Recruiting |
NCT05138848 -
Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease
|
N/A | |
Recruiting |
NCT06186167 -
Amyloidosis Incidence in High-Risk Cardiac Device Patients
|
||
Recruiting |
NCT06048601 -
18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis
|
N/A | |
Active, not recruiting |
NCT04027712 -
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
|
||
Not yet recruiting |
NCT04760171 -
Amyloid Proteins From Medullary Thyroid Cancer and Laryngeal Amyloidosis
|
||
Active, not recruiting |
NCT03431896 -
Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
|
||
Withdrawn |
NCT04984330 -
Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
|
Early Phase 1 | |
Recruiting |
NCT04270175 -
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
|
Phase 2 |